Wells Fargo
CODX

Wells Fargo’s Co-Diagnostics CODX Stock Holding History

Wells Fargo’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$151 Sell
81
-1
-1% -$3 ﹤0.01% 6471
2025
Q4 		$414 Buy
82
+73
+811% +$794 ﹤0.01% 6348
2025
Q3 		$95 Hold
9
– – ﹤0.01% 6390
2025
Q2 		$77 Hold
9
– – ﹤0.01% 6512
2025
Q1 		$85 Sell
9
-30
-77% -$573 ﹤0.01% 6386
2024
Q4 		$881 Hold
39
– – ﹤0.01% 6270
2024
Q3 		$1.47K Buy
39
+30
+333% +$1.15K ﹤0.01% 6087
2024
Q2 		$344 Sell
9
-25
-74% -$909 ﹤0.01% 6173
2024
Q1 		$1.14K Sell
34
-50
-60% -$1.81K ﹤0.01% 6123
2023
Q4 		$3.34K Buy
84
+7
+9% +$247 ﹤0.01% 6020
2023
Q3 		$2.44K Sell
77
-123
-62% -$4.65K ﹤0.01% 6066
2023
Q2 		$6.65K Sell
200
-60
-23% -$2.3K ﹤0.01% 6020
2023
Q1 		$11.5K Buy
260
+6
+2% +$481 ﹤0.01% 5814
2022
Q4 		$19.2K Sell
254
-228
-47% -$21.3K ﹤0.01% 5278
2022
Q3 		$47K Sell
482
-186
-28% -$26K ﹤0.01% 4987
2022
Q2 		$112K Sell
668
-364
-35% -$55.4K ﹤0.01% 4577
2022
Q1 		$191K Buy
1,032
+163
+19% +$33.8K ﹤0.01% 5005
2021
Q4 		$232K Buy
869
+450
+107% +$118K ﹤0.01% 5184
2021
Q3 		$123K Buy
419
+5
+1% +$1.46K ﹤0.01% 5300
2021
Q2 		$102K Sell
414
-8,460
-95% -$2.17M ﹤0.01% 5294
2021
Q1 		$2.54M Buy
8,874
+6,698
+308% +$2.67M ﹤0.01% 3481
2020
Q4 		$607K Sell
2,176
-3,234
-60% -$1.2M ﹤0.01% 4390
2020
Q3 		$2.2M Buy
5,410
+2,904
+116% +$1.49M ﹤0.01% 3228
2020
Q2 		$1.46M Buy
2,506
+2,450
+4,375% +$1.12M ﹤0.01% 3523
2020
Q1 		$13K Buy
+56
New +$9.71K ﹤0.01% 5694

Other funds holding CODX

PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Wells Fargo's CODX Position: Q1 2026 in Review

Wells Fargo reduced its Co-Diagnostics (CODX) stake by 1.2% in Q1 2026, selling an estimated $3 and leaving 81 shares worth $151. The position accounts for ﹤0.01% of the portfolio, ranked #6471.

Wells Fargo first reported a position in CODX in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.54M in Q1 2021. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Wells Fargo held 81 shares of Co-Diagnostics worth $151 as of Q1 2026.
  • Wells Fargo sold 1 Co-Diagnostics share in Q1 2026, an estimated $3.
  • Co-Diagnostics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6471 holding.
  • Wells Fargo first reported a position in Co-Diagnostics in Q1 2020 and has held it in 25 quarters since.
  • Wells Fargo's Co-Diagnostics position peaked at $2.54M in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.